Strong Growth Ahead: Veterinary Oncology Market Size To Grow At Arecord 11% Cagr By 2029

The Veterinary Oncology Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Veterinary Oncology Market Size During the Forecast Period?
The veterinary oncology market size has grown rapidly in recent years. It will grow from $0.4 billion in 2024 to $0.45 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth is due to increasing pet ownership, the humanization of pets, knowledge transfer from human oncology, rising awareness of pet health, and advances in pharmaceutical treatments for animals.

The veterinary oncology market is projected to rise swiftly to $0.69 billion in 2029 at a CAGR of 11.0%. Growth is linked to tailored animal treatments, increasing pet cancer rates, aging pets, improved access to care, and favorable regulations. Trends include better diagnostics, personalized medicine, immunotherapy, targeted drug use, and virtual oncology services.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9533

What Are the High-Growth Segments in the Veterinary Oncology Market?
The veterinary oncology market covered in this report is segmented -

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies
2) By Animal Type: Equine, Canine, Feline, Other Animal Types
3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types

Subsegments:
1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation
2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques
3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents
4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp

What Key Drivers Are Expected to Influence Future Veterinary Oncology Market Growth?
The increasing prevalence of cancer in pets is expected to drive the veterinary oncology market. As more pets are diagnosed with cancer, there is a greater need for veterinary oncology services, which focus on diagnosing and treating cancer in animals. By 2024, an estimated 6 million pet dogs in the U.S. will be diagnosed with cancer, further driving the demand for veterinary oncology.

Which Companies Hold the Largest Share Across Different Veterinary Oncology Market Segments?
Major companies operating in the veterinary oncology market include PetCure Oncology Inc., Zoetis Inc., Karyopharm Therapeutics Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, Rhizen Pharmaceutical SA, AB Science SAS, Pfizer Inc., Takis Biotech GmbH, Qbiotics LLC, Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Invectys S.A., Virbac SA, SeQuent Scientific Limited, Ceva Santé Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, Morphogenesis Inc., ZENOAQ GmbH, Oncovet Clinical Research Inc.

What Veterinary Oncology Market Trends Are Gaining Traction Across Different Segments?
Companies in the veterinary oncology market are focusing on developing neoantigens, which are unique tumor-specific antigens that arise from mutations in cancer cells. Neoantigens are protein fragments produced due to genetic mutations within the tumor's DNA, distinguishing them from normal antigens in healthy tissues. For example, in October 2024, a US-based biotechnology company launched a cancer vaccine trial for dogs, utilizing neoantigens to develop cancer vaccines and other immunotherapies designed to target cancer cells without affecting normal cells.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report

What Are the Emerging Geographies for The Veterinary Oncology Market Growth?
The countries covered in the veterinary oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Veterinary Oncology Market?
2. What is the CAGR expected in the Veterinary Oncology Market?
3. What Are the Key Innovations Transforming the Veterinary Oncology Industry?
4. Which Region Is Leading the Veterinary Oncology Market?

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.